Pure Global AI
NCT06122623Not yet recruiting

Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia

Universitas AirlanggaClinicalTrials.govother
Verified
Study focus
Disease/Condition
Dementia
Drug/Device/Intervention
Health Education
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Universitas Airlangga
Timeline & enrollment
Phase
N/A
Start date
Nov 22, 2023
End date
Jul 30, 2024
Enrollment
400 participants
Primary outcome

Attitude toward people living with dementia

Summary

The aim of this single-arm pre-post study is to examine the effectiveness of gaming-based
 dementia educational programs for enhancing healthcare students' attitudes toward people
 living with dementia (PLWD). The main questions we intend to answer follow:
 
 - What are the attitudes toward PLWD, intentions to help PLWD, knowledge of dementia, and
 stigma of PLWD before and after participation in the gaming-based dementia education
 program?
 
 - What is the effect of gaming-based dementia education programs on enhancing attitudes
 toward PLWD?
 
 Participants will volunteer for the class education program, which will last about 90
 minutes. Participants can attend the class only once. This education program based on gaming
 tools will be structured with a lecture on dementia, N-impro (gaming tools), and bad/good
 short dramas. The gaming education program will be included in dementia-related courses.

ICD-10 classifications
Unspecified dementiaAlzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecifiedDementia in other diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06122623
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06122623 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitas Airlangga and is currently Not yet recruiting. The study focuses on Dementia. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.